Emergent BioSolutions Inc. announced that the appointment of Paul Williams, Emergent's current SVP government/MCM business, as Senior Vice President, ProductsBusiness to lead the company's MCM and commercial products business, including NARCAN® Nasal Spray. Paul will report directly to Robert G. Kramer, President and Chief Executive Officer. Newly created Science and Development (S&D) function that unites research, product development, and clinical teams. The S&D function will be led by Kelly Warfield, Senior Vice President, Science and Development, and reporting to Adam Havey, Chief Operating Officer.

The realigned S&D team will focus on programs that support the life cycle plans for the licensed products while growing the products and services businesses over the long term. Due to the realignment of these functions and the sharper focus on the core businesses, the following changes to the executive management team: Departure of Atul Saran, EVP and Chief Strategy and Development Officer, effective March 17. Strategy and Development teams will report to Stephanie Duatschek, Chief Strategy and Transformation Officer.Departure of Katy Strei, EVP and Chief Human Resource Officer, effective March 17.

Michelle Pepin is being promoted to Senior Vice President and Chief Human Resource Officer, effective immediately.